Compounding Pharmacies Market, By Product Type, By Application (Pediatric, Adults, Geriatric, Veterinary), By Therapeutic areas (Pain Management, Hormone Replacement Therapy (HRT), Dermatology, Specialty Drugs), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Pharmaceutical Dosage Alteration (PDA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Compounding Pharmacies Market size was valued at USD 12,608.7 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.
Specialized pharmaceutical compounding facilities play a pivotal and distinctive role within the pharmaceutical industry. They are responsible for carefully amalgamating, altering, or fusing various substances to create tailor-made prescriptions that cater to individual patient requirements. To craft compounded medications, it is imperative that compounding pharmacies exclusively utilize pure, pharmaceutical-grade ingredients. These ingredients must be sourced from facilities that maintain FDA registration, ensuring the highest standards of quality and safety.
Distinguishing compounded medications from their conventional counterparts often involves unique labeling practices. Unlike the standardized labeling conventions employed for FDA-approved pharmaceuticals, compounded medicine labels do not adhere to a rigid structure. Regulations governing these labels also exhibit significant variations, reflecting the distinct nature of compounded pharmaceuticals within the healthcare landscape.
Compounding Pharmacies Market- Market Dynamics
- Increasing prevalence of chronic disease, increase in old age population, and improved life expectancy expected to propel market demand
Extended therapeutic interventions often become imperative in addressing persistent medical conditions. Compounding pharmacies play a pivotal role in tailoring pharmaceuticals to meet the specific needs of patients, optimizing dosages, formulations, and enhancing overall effectiveness or tolerability for individuals with unique requirements. According to data from the National Health Council, chronic illnesses, which are typically long-lasting and challenging to cure, affect a substantial portion of the U.S. population, approximately 133 million Americans, accounting for over 40% of the nation\'s total inhabitants. Projections indicate that by the year 2020, this number is expected to swell to an estimated 157 million, with a significant subset of 81 million grappling with multiple health conditions.
The increasing elderly demographic underscores a growing demand for specialized geriatric care, encompassing both healthcare services and tailored facilities catering to the unique needs of seniors. As life expectancy continues to rise, the focus on preventive medicine takes center stage in preserving and enhancing the quality of life for individuals in their advanced years. This trend fuels growth in sectors such as wellness, nutrition, and health screening, presenting substantial opportunities for advancement.
Emerging economies offer a fertile ground for expansion, particularly as awareness levels and income levels rise in these regions. As these nations progress, the demand for personalized medical treatments is likely to escalate. However, it is essential to acknowledge that compounding pharmacies may face stringent regulatory oversight at times, posing challenges to their market expansion endeavors.
Compounding Pharmacies Market- Key Insights
- As outlined in the analysis provided by our research analyst, the global Compounding Pharmacies market is poised for steady growth, with an anticipated annual Compound Annual Growth Rate (CAGR) of approximately 6.3% during the forecast period spanning from 2023 to 2030.
- The Compounding Pharmacies industry is expected to experience robust expansion, driven by the increasing emphasis on sustainable growth practices.
- In terms of product type segmentation, the year 2022 witnessed Oral products occupying the largest market share.
- Regarding therapeutic areas, Hormone Replacement Therapy (HRT) emerged as the dominant category in 2022.
- Within the realm of application segmentation, Geriatric-focused pharmaceuticals held the leading position in 2022, catering to the healthcare needs of the elderly population.
- Regionally, North America emerged as the primary revenue contributor in the Compounding Pharmacies market during the year 2022, highlighting its significance in this industry\'s landscape.
Compounding Pharmacies Market- Segmentation Analysis:
The Global Compounding Pharmacies Market exhibits a comprehensive segmentation structure, encompassing various facets including Product Type, Therapeutic Areas, Application, Compounding Type, and Regional distribution.
Within this market, it is further categorized into seven distinct product types, namely Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Mouthwashes. Notably, the Oral segment emerges as the dominant force within this landscape. This prominence can be attributed to its favorable attributes, including ease of administration, high patient compliance rates, and a wide spectrum of formulation options such as tablets, capsules, liquids, and suspensions. Consequently, the oral route stands out as one of the most preferred and versatile drug delivery methods.
Compounding Pharmacies Market- Geographical Insights
In terms of geographical presence, the Compounding Pharmacies market extends its footprint across diverse regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions, in turn, are further subdivided based on individual countries that contribute to the market\'s dynamics.
North America emerges as the frontrunner in driving market growth, primarily attributed to a heightened awareness of compounding medications within the region. Moreover, the proliferation of healthcare facilities plays a pivotal role in propelling this dominance. Notably, both the United States and Canada have significantly invested in bolstering their healthcare infrastructure, encompassing not only hospitals but also specialized clinics, nursing homes, and various healthcare settings where compounded pharmaceuticals hold substantial value. It\'s worth noting that the U.S. Health Care from a Global Perspective reported that in 2021, the United States allocated 17.8 percent of its gross domestic product (GDP) towards healthcare spending, nearly doubling the average expenditure of OECD countries.
Following North America, Europe stands as the second-largest market for Compounding Pharmacies. This positioning can be attributed to factors such as heightened awareness, regulatory clarity, robust economic stability, and a culture of technological innovation that prevails within the continent.
Compounding Pharmacies Market- Competitive Landscape:
Within the compounding pharmacies industry, the competitive landscape is characterized by a diverse array of participants, including prominent global players, regional contenders, and independent local pharmacies. These entities engage in competitive dynamics rooted in various factors such as quality standards, service breadth, adherence to regulatory requirements, technological advancements, and geographical reach.
Market share distribution exhibits variability contingent on the specific geographic location and the particular niche within the compounding sector that each company specializes in. Larger corporations boasting multiple locations may exert dominance in terms of revenue generation, yet regional and independent pharmacies also wield significant influence, particularly within localized market segments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL COMPOUNDING PHARMACIES MARKET KEY PLAYERS
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine’s Pharmacy
- Rx3 Compounding Pharmacy
- B Braun Melsungen AG
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
GLOBAL COMPOUNDING PHARMACIES MARKET, BY PRODUCT TYPE
- Oral
- Capsule
- Tablets
- Mixtures
- Lollipops
- Lozenges
- Topical
- Gels
- Ointments
- Cream
- Lotions
- Rectal
- Parenteral
- Nasal
- Ophthalmic
- Mouthwashes
GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA
- Pain Management
- Hormone Replacement Therapy (HRT)
- Dermatology
- Specialty Drugs
GLOBAL COMPOUNDING PHARMACIES MARKET, BY APPLICATION
- Pediatric
- Adults
- Geriatric
- Veterinary
GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Dosage Alteration (PDA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Others
GLOBAL COMPOUNDING PHARMACIES MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Compounding Pharmacies Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Compounding Pharmacies Market Snippet by Product Type
2.1.2. Compounding Pharmacies Market Snippet by Application
2.1.3. Compounding Pharmacies Market Snippet by Compounding Type
2.1.4. Compounding Pharmacies Market Snippet by Therapeutic Areas
2.1.5. Compounding Pharmacies Market Snippet by Country
2.1.6. Compounding Pharmacies Market Snippet by Region
2.2. Competitive Insights
3. Compounding Pharmacies Key Market Trends
3.1. Compounding Pharmacies Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Compounding Pharmacies Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Compounding Pharmacies Market Opportunities
3.4. Compounding Pharmacies Market Future Trends
4. Compounding Pharmacies Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Compounding Pharmacies Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Compounding Pharmacies Market Landscape
6.1. Compounding Pharmacies Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Compounding Pharmacies Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
7.1.2. Oral
7.1.2.1. Capsule
7.1.2.2. Tablets
7.1.2.3. Mixtures
7.1.2.4. Lollipops
7.1.2.5. Lozenges
7.1.3. Topical
7.1.3.1. Gels
7.1.3.2. Ointments
7.1.3.3. Cream
7.1.3.4. Lotions
7.1.4. Rectal
7.1.5. Parenteral
7.1.6. Nasal
7.1.7. Ophthalmic
7.1.8. Mouthwashes
8. Compounding Pharmacies Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Pediatric
8.1.3. Adults
8.1.4. Geriatric
8.1.5. Veterinary
9. Compounding Pharmacies Market – By Compounding Type
9.1. Overview
9.1.1. Segment Share Analysis, By Compounding Type, 2022 & 2030 (%)
9.1.2. Pharmaceutical Ingredient Alteration (PIA)
9.1.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
9.1.4. Pharmaceutical Dosage Alteration (PDA)
9.1.5. Others
10. Compounding Pharmacies Market – By Therapeutic Areas
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
10.1.2. Pain Management
10.1.3. Hormone Replacement Therapy (HRT)
10.1.4. Dermatology
10.1.5. Specialty Drugs
11. Compounding Pharmacies Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Compounding Pharmacies Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Compounding Pharmacies Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Compounding Pharmacies Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Compounding Pharmacies Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Compounding Pharmacies Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Compounding Pharmacies Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Avella Specialty Pharmacy
12.2.2. Central Admixture Pharmacy Services
12.2.3. Fagron
12.2.4. Fresenius Kabi AG
12.2.5. PharMEDium Services
12.2.6. Institutional Pharmacy Solutions
12.2.7. Cantrell Drug Company
12.2.8. Triangle Compounding Pharmacies
12.2.9. Lorraine’s Pharmacy
12.2.10. Rx3 Compounding Pharmacy
12.2.11. B Braun Melsungen AG
12.2.12. Clinigen Group PLC
12.2.13. QuVa Pharma
12.2.14. ITC Compounding Pharmacy
12.2.15. Advanced Pharmacy.
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
